Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer

Urologic Clinics of North America

Volumn 23, Issue 4, 1996, Pages 557-573

  Hugosson, J ^a   Aus, G ^a   Norlen, L ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER THERAPY; CONSERVATIVE TREATMENT; HUMAN; MALE; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TREATMENT PLANNING;

EID: 0030454717     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70336-0     Document Type: Article

References (58)

1. H.O. Adami B.J. Norlén B. Malker Long-term survival in prostatic carcinoma with special reference to age as a prognostic factor Scand J Urol Nephrol 20 1986 107
2. J. Adolfsson Deferred treatment of low grade stage T3 prostate cancer without distant metastases J Urol 149 1993 326
3. J. Adolfsson G. Steineck Whitmore W.F. Jr Recent results of management of palpable clinically localized prostate cancer Cancer 72 1993 310
4. P.C. Albertsen D.G. Fryback B.E. Storer Long-term survival among men with conservatively treated localized prostate cancer JAMA 274 1995 626
5. A.G. Aprikian Z.F. Zhang W.R. Fair Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients Cancer 74 1994 1768
6. G. Aus J. Hugosson L. Norlén Long-term survival and mortality in prostate cancer treated with noncurative intent J Urol 154 1995 460
7. G. Aus J. Hugosson L. Norlén Need for hospital care and palliative treatment in prostate cancer treated with noncurative intent J Urol 154 1995 466
8. G. Aus E. Pileblad J. Hugosson Impact of competing mortality on the cancer-related mortality in localized prostate cancer Urology 46 1995 672
9. M.C. Benson I.S. Whang C.A. Olsson The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen J Urol 147 1992 817
10. M.L. Blute H. Zincke G.M. Farrow Long-term follow-up of young patients with stage A carcinoma of the prostate J Urol 136 1986 840
11. C.C. Boring T.S. Squires T. Tong Cancer statistics 1994 CA Cancer J Clin 44 1994 7
12. N. Breslow C.W. Chan G. Dhom Latent carcinoma of prostate at autopsy in seven areas Int J Cancer 20 1977 680
13. Cancer Registry of National Board of Health and Welfare Cancer Incidence in Sweden 1993 1994 Fritzes Stockholm
14. P. Carlsson H. Hjertberg B. Jönsson The cost of prostate cancer in a defined population Scand J Urol Nephrol 23 1989 93
15. W.J. Catalona D.S. Smith T.L. Ratliff Measurement of prostate-specific antigen in serum as a acreening test for prostate cancer N Engl J Med 324 1991 1156
16. Causes of Death 1969 and 1970, Official Statistics of Sweden 1971 National Central Bureau of Statistics Stockholm
17. Causes of Death 1993, Official Statistics of Sweden 1995 National Central Bureau of Statistics Stockholm
18. G.W. Chodak Letter to the Editor J Urol 155 1996 2039
19. G.W. Chodak R.A. Thistedt G.S. Gerber Results of conservative management of clinically localized prostate cancer N Engl J Med 330 1994 242
20. J.I. Epstein G. Paull J.C. Eggleston Prognosis of untreated stage A1 prostatic carcinoma: A study of 94 cases with extended followup J Urol 136 1986 837
21. C. Flemming J.H. Wasson P.C. Albertsen A descision analysis of alternative treatment strategies for clinically localized prostate cancer: Prostate patient outcomes research team JAMA 269 1993 2650
22. P.H. Gann C.H. Hennekens M.J. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer JAMA 273 1995 289
23. N.J. George Natural history of localized prostatic cancer managed by conservative therapy alone Lancet 1 1988 492
24. R.P. Gibbons Correa R.J. Jr G.E. Brannen Total prostatectomy for clinically localized prostate cancer: Long-term results J Urol 141 1989 564
25. C.M. Goodman A. Busuttil G.D. Chisholm Age, size and grade of tumor predict prognosis in incidentally diagnosed carcinoma of the prostate Br J Urol 62 1988 576
26. H. Grönberg Damber J.-E. L. Damber A population-based study of mortality from prostatic cancer in northern Sweden Scand J Urol Nephrol 29 suppl 174 1995 27
27. H. Grönberg Damber J.-E. H. Jonsson Patient age as a prognostic factor in prostate cancer J Urol 152 1994 892
28. T. Hakulinen On long-term relative survival rates J Chron Dis 30 1977 431 443
29. J. Hugosson G. Aus Initial experience of cryotherapy for localized prostate cancer Scand J Urol Nephrol 29 suppl 174 1995 21
30. J. Hugosson G. Aus Natural evolution of prostate cancer Endocrine-Related Cancer 1996 in press
31. J. Hugosson G. Aus C. Bergdahl Prostate cancer mortality inpatients surviving more than 10 years after diagnosis J Urol 154 1995 2115
32. J. Hugosson G. Aus J. Persson The hospital costs for treating prostate cancer patient during their last year alive is highest for those dying from prostate cancer after long duration Anticancer Res 1996 submitted for publication
33. J Hugosson, G Aus, J Persson, The hospital costs for treating prostate cancer patient during their last year alive is highest for those dying from prostate cancer after long duration. Anticancer Res, 1996, submitted for publication
34. P. Iversen P.O. Madsen D.K. Corle Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study Scand J Urol Nephrol Suppl 172 1995 65
35. J.E. Johansson H.O. Adami S.O. Andersson High 10-year survival rate in patients with early, untreated prostatic cancer JAMA 267 1992 2191
36. Johansson J.-E. L. Holmberg 15-year survival in a cohort of prostate cancer patients Scand J Urol Nephrol 29 suppl 174 1995 26
37. Johansson J.-E. L. Holmberg The natural course of prostate cancer: Updated Örebro study Scand J Urol Nephrol 29 suppl 174 1995 25
38. G.W. Jones Prospective, conservative management of localized prostate cancer Cancer 70 1992 307
39. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457
40. L.L. Kupper A.J. McMichael M.J. Symons On the utility of proportional mortality analysis J Chron Dis 31 1978 15
41. F. Labrie Extensive personal experience. Combination of screening and preoperative endocrine therapy: The potential for an important decrease in prostate cancer mortality J Clin Endocrinol Metab 80 1995 2002
42. H. Lepor A.W. Kimball P.C. Walsh Cause-specific actuarial survival analysis: A useful method for reporting survival data in men with clinically localized carcinoma of the prostate J Urol 141 1989 82
43. S.P. Lerner C. Seale-Hawkins Carlton C.E. Jr The risk of dying of prostate cancer in patients with clinically localized disease J Urol 146 1991 1040
44. M.S. Litwin R.D. Hays A. Fink Quality-of-life outcomes in men treated for localized prostate cancer JAMA 273 1995 129
45. M. Menon B.G. Parulkar S. Bakre Should we treat localized prostate cancer? An opinion Urology 46 1995 607
46. B. Moskovitz S. Nitecki D. Richter-Levin Cancer of the prostate: Is there a need for agressive treatment? Urol Int 42 1987 49
47. B.J. Norlén Survival and mortality in prostate cancer. A study based on the Swedish cancer registry Acta Oncol 30 1991 141
48. B. Otnes S. Harvei S.D. Fosså The burden of prostate cancer from diagnosis until death Br J Urol 76 1995 587
49. D.F. Paulsson Impact of radical prostatectomy in the management of clinically localized disease J Urol (part 2) 152 1994 1826
50. W.A. Sakr G.P. Haas B.F. Cassin The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients J Urol 150 1993 379
51. F.H. Schröder P. Hermanek L. Denis The TNM Classification of prostate cancer Prostate 4 suppl 4 1992 129
52. T.A. Stamey J.N. Kabalin J.E. McNeal Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients J Urol 141 1989 1076
53. M. Stenbeck Cancer survival in Sweden Acta Oncol 34 suppl 4 1995 49
54. C.H. Stenman Serum concentrations of prostate specific antigen and its complex before diagnosis of prostate cancer Lancet 344 1994 1594
55. G. Tibblin L. Welin R. Bergström The value of prostate specific antigen in early diagnosis of prostate cancer: The study of men born in 1913 J Urol 154 1995 1386
56. R.J. Veenema E.O. Gursel J.K. Lattimer Radical retropubic prostatectomy for cancer: A 20-year experience J Urol 117 1977 330
57. Whitmore W.F. Jr J.A. Warner I.M. Thompson Expectant management of localized prostatic cancer Cancer 67 1991 1091
58. H. Zincke J.E. Oesterling M.L. Blute Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer J Urol 152 1994 1850